info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Edoxaban Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142932 |
| CAS No | NA |
| Mol.F. | C24H27N5O6S |
| Mol.Wt. | 513.57 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142933 |
| CAS No | NA |
| Mol.F. | C16H24N4O4S |
| Mol.Wt. | 368.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142934 |
| CAS No | NA |
| Mol.F. | C19H24N4O7S |
| Mol.Wt. | 452.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142935 |
| CAS No | NA |
| Mol.F. | C16H19N3O3 |
| Mol.Wt. | 301.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142936 |
| CAS No | NA |
| Mol.F. | C16H20N4O5S |
| Mol.Wt. | 380.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142937 |
| CAS No | NA |
| Mol.F. | C24H31N5O8S |
| Mol.Wt. | 549.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142938 |
| CAS No | NA |
| Mol.F. | C24H33N5O7S |
| Mol.Wt. | 535.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142939 |
| CAS No | NA |
| Mol.F. | C15H27N3O2 |
| Mol.Wt. | 281.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142940 |
| CAS No | NA |
| Mol.F. | C20H26N4O8S |
| Mol.Wt. | 482.51 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142941 |
| CAS No | NA |
| Mol.F. | C16H18ClN3O5S |
| Mol.Wt. | 399.85 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142942 |
| CAS No | NA |
| Mol.F. | C16H19N3O6S |
| Mol.Wt. | 381.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142943 |
| CAS No | NA |
| Mol.F. | C21H28N4O7S |
| Mol.Wt. | 480.54g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142944 |
| CAS No | NA |
| Mol.F. | C26H37N5O6S |
| Mol.Wt. | 547.67g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142945 |
| CAS No | NA |
| Mol.F. | C18H20N4O8S |
| Mol.Wt. | 452.44 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142946 |
| CAS No | NA |
| Mol.F. | C18H18N4O10S |
| Mol.Wt. | 482.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142947 |
| CAS No | NA |
| Mol.F. | C7H17N3O2 |
| Mol.Wt. | 175.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
